AAV Capsid Database

Database of adeno-associated virus (AAV) capsid variants and their tropism profiles. Essential for selecting the right AAV serotype for inner ear gene therapy.

What It Does

  • Catalog of natural and engineered AAV capsids
  • Tropism profiles (which tissues each serotype infects)
  • Packaging capacity per serotype
  • Neutralizing antibody cross-reactivity data
  • Engineering strategies (directed evolution, rational design)

How to Use

Web

Key Serotypes for Inner Ear

SerotypeInner Ear TropismNotes
AAV1IHC + OHCGood transduction, used in OTOF trials
AAV2IHC primarilyHistorical default
AAV9Broad CNS + some IHCBBB crossing
AAV-PHP.eBCNSMay reach spiral ganglion
Anc80L65OHC + IHCAncestral reconstructed, good for cochlea
AAV-ieIHC + OHCEngineered for inner ear

Verified Status

VERIFIED — compiled inner ear AAV serotype data from literature:

  • Anc80L65: IHC + OHC tropism, 5-10% seroprevalence, BEST candidate for STRC (Landegger 2017)
  • AAV1: IHC + OHC, ~30% seroprevalence, used in OTOF trials
  • AAV9: IHC + some OHC, ~40% seroprevalence
  • AAV-ie: IHC + OHC engineered, seroprevalence unknown (Tan 2019)
  • STRC CDS 5,325bp exceeds AAV limit (~4.7kb) → mini-STRC (700-1775) = 3,228bp FITS all serotypes

STRC Research Usage

Results (April 2026)

  • Capacity analysis DONE: mini-STRC (700-1775) = 3,228bp → FITS all AAV serotypes (limit ~4.7kb). Full STRC 5,325bp does NOT fit.
  • OHC serotypes DONE: Anc80L65 and AAV-ie have best OHC tropism. AAV1 also transduces OHC.
  • Immune profile DONE: Anc80L65 ~5-10% seroprevalence (lowest). AAV1 ~30%, AAV9 ~40%. Misha age 4 = low seroprevalence window.
  • Next: delivery route comparison (round window vs canalostomy) — requires clinical literature review

Connections